Management of Uncontrolled Hypertension in Elderly Patients Post-Angioplasty

Rationale for Adding a Diuretic

• The European and international guidelines recommend adding a thiazide or thiazide-like diuretic to create the evidence-based triple therapy combination of ARB + CCB + diuretic when blood pressure remains uncontrolled on a two-drug combination of ARB plus CCB 1

Specific Diuretic Selection

• Chlorthalidone 12.5-25mg daily is preferred over hydrochlorothiazide due to its longer duration of action and superior outcomes data 1
• Hydrochlorothiazide 25-50mg daily is an acceptable alternative if chlorthalidone is unavailable or not tolerated 1

Critical Monitoring After Adding Diuretic

• Check serum potassium and creatinine 2-4 weeks after initiating diuretic therapy to detect hypokalemia or changes in renal function 1
• Reassess blood pressure within 2-4 weeks, with the goal of achieving target BP within 3 months of treatment modification 1
• Target blood pressure is <140/90 mmHg minimum, ideally <130/80 mmHg for high-risk patients with coronary artery disease 1, 2

Special Considerations for Elderly Post-Angioplasty Patients

• Avoid lowering diastolic blood pressure below 60 mmHg in elderly patients with ischemic heart disease, as this may compromise coronary perfusion 2
• Blood pressure should be stable and controlled before any coronary intervention, though this may not be possible in patients who have already undergone angioplasty 2

If Blood Pressure Remains Uncontrolled on Triple Therapy

• Add spironolactone 25-50mg daily as the preferred fourth-line agent for resistant hypertension 1
• Monitor potassium closely when adding spironolactone to telmisartan, as the combination of ARB plus mineralocorticoid receptor antagonist significantly increases hyperkalemia risk 1

Common Pitfalls to Avoid

• Do not add a beta-blocker as the third agent unless there are compelling indications such as angina, post-MI, heart failure with reduced ejection fraction, or need for heart rate control 1
• Do not combine telmisartan with an ACE inhibitor, as this increases adverse events without additional cardiovascular benefit 1
• Do not delay treatment intensification in elderly patients with coronary disease, as prompt action reduces cardiovascular risk 1

Lifestyle Modifications to Reinforce

• Sodium restriction to <2g/day, weight management, regular aerobic exercise, and alcohol limitation provide additive blood pressure reductions of 10-20 mmHg and should be reinforced at every visit 1